IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
This Quarter Return
+16.64%
1 Year Return
+40.53%
3 Year Return
+328.04%
5 Year Return
+535.34%
10 Year Return
–
AUM
$762M
AUM Growth
+$762M
(+58%)
Cap. Flow
+$253M
Cap. Flow
% of AUM
33.18%
Top 10 Holdings %
Top 10 Hldgs %
36.2%
Holding
102
New
30
Increased
25
Reduced
12
Closed
27
Top Buys
| 1 |
Cigna
CI
|
$50.5M |
| 2 |
Zimmer Biomet
ZBH
|
$43.7M |
| 3 |
McKesson
MCK
|
$30.8M |
| 4 |
Tenet Healthcare
THC
|
$18.9M |
| 5 |
Boston Scientific
BSX
|
$17M |
Top Sells
| 1 |
Stryker
SYK
|
$14.3M |
| 2 |
Teleflex
TFX
|
$11.7M |
| 3 |
Cardinal Health
CAH
|
$11.5M |
| 4 |
Biogen
BIIB
|
$11.1M |
| 5 |
uniQure
QURE
|
$10.1M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Privia Health
PRVA
$2.85B
| $5.22M | 0.65% |
+200,000
| New | +$5.22M |
|
52
Envista
NVST
$3.37B
| $5.08M | 0.63% |
150,000
-2,000
| -1% | -$67.7K |
|
53
Teladoc Health
TDOC
$1.37B
| $5.06M | 0.63% |
+200,000
| New | +$5.06M |
|
54
Cencora
COR
$57.2B
| $5M | 0.62% |
+26,000
| New | +$5M |
|
55
Amicus Therapeutics
FOLD
$2.42B
| $4.86M | 0.6% |
387,000
+82,000
| +27% | +$1.03M |
|
|
LBPH
56
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $4.39M | 0.54% |
598,000
+16,000
| +3% | +$117K |
|
57
Cross Country Healthcare
CCRN
$420M
| $4.35M | 0.54% |
+155,000
| New | +$4.35M |
|
58
BioMarin Pharmaceuticals
BMRN
$11.3B
| $4.33M | 0.54% |
50,000
-50,000
| -50% | -$4.33M |
|
59
Dentsply Sirona
XRAY
$2.77B
| $4M | 0.5% |
+100,000
| New | +$4M |
|
60
BioNTech
BNTX
$24.1B
| $3.89M | 0.48% |
+36,000
| New | +$3.89M |
|
|
SAGE
61
DELISTED
Sage Therapeutics
SAGE
| $3.76M | 0.47% |
80,000
-165,000
| -67% | -$7.76M |
|
62
Prothena Corp
PRTA
$452M
| $3.55M | 0.44% |
+52,000
| New | +$3.55M |
|
63
Akero Therapeutics
AKRO
$3.65B
| $3.27M | 0.4% |
70,000
| – | – |
|
64
Supernus Pharmaceuticals
SUPN
$2.52B
| $2.25M | 0.28% |
75,000
-50,000
| -40% | -$1.5M |
|
65
Keros Therapeutics
KROS
$638M
| $2.09M | 0.26% |
52,000
+2,000
| +4% | +$80.4K |
|
66
Protagonist Therapeutics
PTGX
$3.62B
| $2.07M | 0.26% |
+75,000
| New | +$2.07M |
|
67
Allogene Therapeutics
ALLO
$249M
| $2.05M | 0.25% |
412,000
+7,000
| +2% | +$34.8K |
|
68
Elanco Animal Health
ELAN
$8.62B
| $2.01M | 0.25% |
+200,000
| New | +$2.01M |
|
69
Terns Pharmaceuticals
TERN
$651M
| $1.58M | 0.2% |
180,000
+80,000
| +80% | +$700K |
|
70
Dyne Therapeutics
DYN
$1.92B
| $698K | 0.09% |
62,000
+5,000
| +9% | +$56.3K |
|
|
EXAI
71
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| – | – |
-152,000
| Closed | -$806K |
|
|
KDNY
72
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – |
-152,000
| Closed | -$3.52M |
|
|
RXDX
73
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| – | – |
-30,000
| Closed | -$3.22M |
|
74
Labcorp
LH
$22.8B
| – | – |
-23,280
| Closed | -$4.59M |
|
75
Acadia Healthcare
ACHC
$2.15B
| – | – |
-61,000
| Closed | -$4.41M |
|